Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2204]

New 'game plan' for oncologists reflects rapid advances and need for immediate information

New 'game plan' for oncologists reflects rapid advances and need for immediate information

European Commission approves extension for carfilzomib to treat relapsed multiple myeloma

European Commission approves extension for carfilzomib to treat relapsed multiple myeloma

NICE recommends degarelix for men with advanced hormone-dependent prostate cancer and spinal metastases

NICE recommends degarelix for men with advanced hormone-dependent prostate cancer and spinal metastases

NICE issues preliminary decision not to recommend osimertinib for locally advanced or metastatic lung cancer

NICE issues preliminary decision not to recommend osimertinib for locally advanced or metastatic lung cancer

Nivolumab and ipilimumab combination approved for melanoma treatment on NHS

Nivolumab and ipilimumab combination approved for melanoma treatment on NHS

ASCO 2016: Significant cost differences between breast cancer chemotherapy regimens identified

ASCO 2016: Significant cost differences between breast cancer chemotherapy regimens identified

Surrogate endpoints poor proxy for survival in cancer drug approval process

Surrogate endpoints poor proxy for survival in cancer drug approval process

Evidence of link between cancer and light therapy inconclusive but warrants consideration

Evidence of link between cancer and light therapy inconclusive but warrants consideration

Consensus statement on optimizing management of EGFR mutation positive NSCLC patients

Consensus statement on optimizing management of EGFR mutation positive NSCLC patients

Proteins key to unlocking cancer for US initiative the National Cancer Moonshot

Proteins key to unlocking cancer for US initiative the National Cancer Moonshot

More from ecancer